CINECA IRIS Institutional Research Information System

CALDERONE, VINCENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.897
AS - Asia 10.582
EU - Europa 8.689
SA - Sud America 1.584
AF - Africa 427
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 8
Totale 42.219
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.267
SG - Singapore 3.457
IT - Italia 3.305
CN - Cina 3.192
HK - Hong Kong 1.814
BR - Brasile 1.352
SE - Svezia 1.312
DE - Germania 1.000
BG - Bulgaria 716
VN - Vietnam 624
CA - Canada 493
GB - Regno Unito 456
TR - Turchia 429
RU - Federazione Russa 355
FI - Finlandia 347
KR - Corea 297
FR - Francia 258
UA - Ucraina 246
IN - India 204
AT - Austria 200
CI - Costa d'Avorio 185
PL - Polonia 127
JP - Giappone 96
BD - Bangladesh 76
CH - Svizzera 75
MX - Messico 75
NL - Olanda 71
AR - Argentina 70
IQ - Iraq 59
SN - Senegal 57
ZA - Sudafrica 55
BE - Belgio 46
ID - Indonesia 39
PK - Pakistan 39
EC - Ecuador 37
SA - Arabia Saudita 36
ES - Italia 31
UZ - Uzbekistan 30
VE - Venezuela 29
CO - Colombia 28
AU - Australia 26
MA - Marocco 26
NG - Nigeria 24
GR - Grecia 22
KE - Kenya 21
IL - Israele 20
PE - Perù 19
CL - Cile 18
AE - Emirati Arabi Uniti 15
HU - Ungheria 15
IR - Iran 15
JM - Giamaica 15
CZ - Repubblica Ceca 14
AZ - Azerbaigian 13
IE - Irlanda 13
LT - Lituania 13
PS - Palestinian Territory 13
KZ - Kazakistan 12
MY - Malesia 12
PY - Paraguay 12
BO - Bolivia 11
EG - Egitto 11
JO - Giordania 11
NP - Nepal 11
CR - Costa Rica 10
PH - Filippine 10
TN - Tunisia 10
DZ - Algeria 9
LB - Libano 9
TW - Taiwan 9
DO - Repubblica Dominicana 8
KG - Kirghizistan 8
UY - Uruguay 8
BJ - Benin 7
AL - Albania 6
MD - Moldavia 6
NI - Nicaragua 6
SK - Slovacchia (Repubblica Slovacca) 6
BY - Bielorussia 5
DK - Danimarca 5
ET - Etiopia 5
EU - Europa 5
HN - Honduras 5
HR - Croazia 5
MK - Macedonia 5
NZ - Nuova Zelanda 5
PT - Portogallo 5
RO - Romania 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
AO - Angola 4
EE - Estonia 4
OM - Oman 4
RS - Serbia 4
AM - Armenia 3
BB - Barbados 3
BH - Bahrain 3
GE - Georgia 3
LK - Sri Lanka 3
LU - Lussemburgo 3
Totale 42.173
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.130
Ashburn 2.125
Singapore 1.859
Hong Kong 1.797
Ann Arbor 1.651
Fairfield 1.557
Houston 1.379
Chandler 1.240
Santa Clara 1.179
Dallas 994
Serra 728
Sofia 715
Milan 701
Shanghai 686
Seattle 645
Beijing 638
Wilmington 575
Cambridge 531
New York 501
Boardman 433
Ottawa 390
Hefei 377
Los Angeles 341
Princeton 313
Jacksonville 300
Lawrence 285
Seoul 273
Izmir 265
Medford 235
Nanjing 204
Chicago 200
Dong Ket 186
Abidjan 185
Vienna 181
Des Moines 167
Frankfurt am Main 161
Munich 156
Pisa 141
London 140
Buffalo 138
Istanbul 114
Rome 114
Redondo Beach 111
Florence 108
Dearborn 107
São Paulo 105
Warsaw 103
Ho Chi Minh City 101
San Diego 89
Tokyo 85
Nanchang 84
Boulder 77
Helsinki 75
Redwood City 67
The Dalles 66
Bern 62
Council Bluffs 58
Dakar 57
Hanoi 57
Columbus 56
Marseille 54
Ogden 51
Jüchen 50
Lucca 50
Washington 47
Livorno 46
Shenyang 45
Turku 45
Brussels 44
Kunming 43
Changsha 42
Salt Lake City 42
Grafing 41
Tianjin 41
Rio de Janeiro 40
San Jose 38
Hebei 37
Naples 37
Fuzhou 36
Pune 36
Belo Horizonte 35
Falls Church 33
Guangzhou 32
Norwalk 32
Brasília 31
Nuremberg 31
Atlanta 30
Bremen 29
Jiaxing 29
Phoenix 28
Brooklyn 27
Hangzhou 27
Johannesburg 27
Toronto 27
Auburn Hills 26
Nürnberg 26
Quanzhou 26
Gif-sur-Yvette 25
Lancaster 25
Mexico City 25
Totale 29.834
Salva come PNG Salva come JPEG
Nome #
1,2,3-Triazol-carboxanilides and 1,2,3-triazol-(N-benzyl)-carboxamides as BK-potassium channel activators. XII 374
Different patterns of H2S/NO activity and cross-talk in the control of the coronary vascular bed under normotensive or hypertensive conditions 281
Design and synthesis of 2-oxindole based multi-targeted inhibitors of PDK1/Akt signaling pathway for the treatment of glioblastoma multiforme 279
N(6)-1,3-diphenylurea derivatives of 2-phenyl-9-benzyladenines and 8-azaadenines: Synthesis and biological evaluation as allosteric modulators of A(2A) adenosine receptors 269
R(+)-METHANANDAMIDE INHIBITS EFS-INDUCED CHOLINERGIC RESPONSE IN GUINEA-PIG TRACHEA THROUGH A VR-MEDIATED MECHANISM 262
R+-METHANANDAMIDE INHIBITS TRACHEAL RESPONSE TO ENDOGENOUSLY RELEASED ACETYLCHOLINE VIA CAPSAZEPINE-SENSITIVE RECEPTORS 248
Iminothioethers as Hydrogen Sulfide Donors: From the Gasotransmitter Release to the Vascular Effects 248
The Citrus Flavanone Naringenin Protects Myocardial Cells against Age-Associated Damage 239
Antioxidant, cardiomyocyte anti-ageing properties and phytochemical profile of Citrus bergamia juices 231
Antioxidant and Antisenescence Effects of Bergamot Juice 227
The Citrus Flavonoid Naringenin Protects the Myocardium from Ageing-Dependent Dysfunction: Potential Role of SIRT1 226
New activators of SIRT1 enzyme for the treatment of cardiovascular and cardiometabolic pathologies 226
The citrus flavanone naringenin produces cardioprotective effects in hearts from 1 year old rat, through activation of mitoBK channels 221
The novel H2S-donor 4-carboxyphenyl isothiocyanate promotes cardioprotective effects against ischemia/reperfusion injury through activation of mitoKATP channels and reduction of oxidative stress 216
Hydrogen sulfide releasing capacity of natural isothiocyanates: is it a reliable explanation for the multiple biological effects of brassicaceae? 213
Synthesis and evaluation of multi-functional NO-donor/insulin-secretagogue derivatives for the treatment of type II diabetes and its cardiovascular complications 213
New NO-Releasing Pharmacodynamic Hybrids of Losartan and Its Active Metabolite: Design,Synthesis, and Biopharmacological Properties 210
Protective effect of high-dose montelukast on salbutamol-induced homologous desensitisation in airway smooth muscle. 209
1,4-Benzothiazine ATP-Sensitive Potassium Channel Openers: Modifications at the C-2 and C-6 Positions 209
Anti-Inflammatory Effect of the Natural H2S-Donor Erucin in Vascular Endothelium 207
A NEW NITRIC OXIDE RELEASING ANTI-DIABETIC HYBRID DRUG: FROM THE DESIGN TO THE PHARMACOLOGICAL CHARACTERIZATION 206
Memantine prodrug as a new agent for alzheimer’s disease 206
Nuovi attivatori dell’enzima SIRT1 per il trattamento delle patologie cardiovascolari e cardiometaboliche 205
An update on hybrid drugs in cardiovascular drug research 203
First examples of H2S-releasing glycoconjugates: stereoselective synthesis and anticancer activities 201
1,2,4-Thiadiazolidin-3,5-diones as novel hydrogen sulfide donors 198
The activation of mitochondrial BK potassium channels contributes to the protective effects of naringenin against myocardial ischemia/reperfusion injury 194
Synthesis and biological activity of novel substituted benzanilides as potassium channel activators. V 190
Arylthioamides as H2S Donors:l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo 190
Hydrogen Sulphide: Biopharmacological Roles in the Cardiovascular System and Pharmaceutical Perspectives. 187
In-vitro evaluation of new pharmacodynamic hybrids with insulin secretagogue and NO-donor activity 185
An alternative method to evaluate the nature of an antagonist and its potency. A theoretical approach 184
Matrix metalloproteinase-12 inhibitors: synthesis, structure-activity relationships and intestinal absorption of novel sugar-based biphenylsulfonamide carboxylates 184
AN IN VIVO EXPERIMENTAL METHOD TO PREDICT THE TORSADOGENIC POTENTIALITY OF DRUGS: EVALUATION OF QT PROLONGATION IN ANAESTHETISED GUINEA-PIG 183
D -Penicillamine modulates hydrogen sulfide (H2S) pathway through selective inhibition of cystathionine-γ-lyase 183
NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same? 181
ROLE OF ENDOTHELIAL NO IN THE VASORELAXING EFFECTS INDUCED BY H2S IN CONDUCTANCE AND RESISTANCE RAT ARTERIES 180
Synthesis of 1,8 - naphthyridine derivatives: potential antihypertensive agents. Part VII 179
Prodromal Intestinal Events in Alzheimer's Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition 179
TORSADOGENIC CARDIOTOXICITY OF ANTIPSYCHOTIC DRUGS: A STRUCTURAL FEATURE, POTENTIALLY INVOLVED IN THE INTERACTION WITH CARDIAC HERG POTASSIUM CHANNELS 178
A Series of COX-2 Inhibitors Endowed with NO-Releasing Properties: Synthesis, Biological Evaluation, and Docking Analysis 178
Spirocyclic Benzopyran-based derivatives as new anti-ischemic activators of mitochondrial ATP-sensitive potassium channel 177
Design and synthesis of H2S-donor hybrids: A new treatment for Alzheimer's disease? 177
A simplified empirical approach to evaluate the dissociation constant of a full agonist by the irreversible receptor inactivation method 176
New amido derivatives as potential BKCa potassium channel activators. XI 174
Pharmacological characterization of the vascular effects of aryl isothiocyanates: Is hydrogen sulfide the real player? 174
Metformin conjugates and therapeutic use thereof 173
ANTI-ISCHEMIC PROPERTIES OF A NEW SPIRO-CYCLIC BENZOPYRAN ACTIVATOR OF CARDIAC MITOCHONDRIAL ATP-SENSITIVE POTASSIUM CHANNELS 173
Pharmacological study on the cardiovascular activity of no-sartans, pharmacodynamic hybridsexhibiting at1-antagonist and no-donor properties 172
A modified aortic multiple-ring preparation for functional studies 172
Valore nutraceutico dei flavonoidi presenti nel genere Citrus. Evidenze epidemiologiche, cliniche e pre-cliniche degli effetti protettivi dei Citrus flavanoni sulle funzioni cardiovascolari 171
SYNTHESIS AND BETA-BLOCKING ACTIVITY OF (R,S)-(E)-OXIMEETHERS OF 2,3-DIHYDRO-1,8-NAPHTHYRIDINE AND 2,3-DIHYDROTHIOPYRANO[2,3-B]PYRIDINE: IDENTIFICATION OF BETA 3-ANTAGONISTS 170
VASORELAXING EFFECTS OF H2S IN RAT MESENTERIC ARTERIES 170
Synthesis of 1,8-naphthyridine derivatives: potential antihypertensive agents. Part VIII 169
Voltage-operated potassium (Kv) channels contribute to endothelium-dependent vasorelaxation of carvacrol on rat aorta 169
Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications? 168
VASORELAXATION BY HYDROGEN SULPHIDE INVOLVES ACTIVATION OF KV7 POTASSIUM CHANNELS 167
Large conductance Ca2+-activated K+ channel (BKCa) activating properties of a series of novel N-arylbenzamides: Channel subunit dependent effects 167
(+/-)-NARINGENIN AS LARGE CONDUCTANCE Ca2+-ACTIVATED K+ (BKCa) CHANNEL OPENER IN VASCULAR SMOOTH MUSCLE CELLS 167
New Benzopyran-Based Openers of the Mitochondrial ATP-Sensitive Potassium Channel with Potent Anti-Ischemic Properties 165
NO-Sartans: A New Class of Pharmacodynamic Hybrids as Cardiovascular Drugs 165
Anti-ischemic properties of a new spiro-cyclic benzopyran activator of the cardiac mito-KATP channel 165
Mitochondrial Potassium Channels as Pharmacological Target for Cardioprotective Drugs 165
Dietary Supplementation with the Probiotic SF68 Reinforces Intestinal Epithelial Barrier in Obese Mice by Improving Butyrate Bioavailability 164
Conformationally restrained analogues of sympathomimetic catecholamines: Synthesis and adrenergic activity of 5,6- and 6,7-dihydroxy-3,4-dihydrospiro[naphthalen-1(2H)-2′,5′- morpholines] 164
Differential Effects of Fondaparinux and Bemiparin on Angiogenic and Vasculogenesis-like processes. 164
QT PROLONGATION IN GUINEA PIGS FOR PRELIMINARY SCREENING OF TORSADOGENICITY OF DRUGS AND DRUG-CANDIDATES. II 164
Mitochondriotropic and Cardioprotective Effects of Triphenylphosphonium-Conjugated Derivatives of the Diterpenoid Isosteviol 164
Vasorelaxing effects of flavonoids: investigation on the possible involvement of potassium channels 164
Anticancer properties of erucin, an H2S-releasing isothiocyanate, on human pancreatic adenocarcinoma cells (AsPC-1) 163
The nutraceutical value of olive oil and its bioactive constituents on the cardiovascular system. Focusing on main strategies to slow down its quality decay during production and storage 163
QSAR models for predicting biological properties, developed by combining structure- and ligand-based approaches: an application to the hERG potassium channel inhibition 162
5-(4'-SUBSTITUTED-2'-NITROANILINO)-1,2,3-TRIAZOLES AS NEW POTENTIAL POTASSIUM CHANNEL ACTIVATORS. I 161
VASODILATOR ACTIVITY OF MICHELIA FIGO SPRENG (MAGNOLIACEAE) BY IN VITRO FUNCTIONAL STUDY 160
New spiromorpholone- and spiromorpholine-benzopyrane derivatives as potential activators of mito-KATP channel 159
QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP MODELS FOR PREDICTING BIOLOGICAL PROPERTIES, DEVELOPED BY COMBINING STRUCTURE- AND LIGAND-BASED APPROACHES: AN APPLICATION TO THE HUMAN ETHER-A-GO-GO-RELATED GENE POTASSIUM CHANNEL INHIBITION 159
Antiviral properties of an aqueous extract of a green algae Caulerpa taxifolia (Vahl) C. Agardh. 158
Synthesis and evaluation of antihypertensive activity of 1,8-naphthyridine derivatives. Part X 158
Novel N-substituted indol-3-ylglyoxylamides probing the LDi and L1L2 lipophilic regions of the benzodiazepine receptor site in search for subtype-selective ligands 158
Cardiac ATP-sensitive potassium channels, a potential target for an anti-ischaemic pharmacological strategy 157
H2S-RELEASING PROPERTIES OF NEW THIOAMIDE, IMINOTHIOETHER AND ISOTHIOCYANATE DERIVATIVES 156
1-(1,2,3-TRIAZOL-4-YL)-BENZIMIDAZOLONES, A NEW SERIES OF HETEROCYCLIC DERIVATIVES 156
NOVEL ANALGESIC/ANTI-INFLAMMATORY AGENTS: 1,5-DIARYLPYRROLE NITROOXYALKYL ETHERS AND RELATED COMPOUNDS AS CYCLOOXYGENASE-2 INHIBITING NITRIC OXIDE DONORS 156
Erucin exhibits vasorelaxing effects and antihypertensive activity by H 2 S-releasing properties 155
Intrinsic activity and EC50: the simplest tools for the evaluation of the dissociation constant of a partial agonist 153
By-products from winemaking and olive mill value chains for the enrichment of refined olive oil: Technological challenges and nutraceutical features 152
A New Calcium Oral Controlled-Release System Based on Zeolite for Prevention of Osteoporosis 151
Anti-Inflammatory and Vasorelaxant Effects Induced by an Aqueous Aged Black Garlic Extract Supplemented with Vitamins D, C, and B12 on Cardiovascular System 149
Novel 1,4-benzothiazine derivatives as large conductance Ca(2+)-activated potassium channel openers 149
1,4- and 2,4-substituted-1,2,3-triazoles as potential potassium channel activators. VII. 148
VASORELAXATION BY HYDROGEN SULPHIDE INVOLVES ACTIVATION OF KV7 POTASSIUM CHANNELS 147
A Nutraceutical Strategy to Slowing Down the Progression of Cone Death in an Animal Model of Retinitis Pigmentosa 147
Synthesis and b-blocking activity of (R,S)-(E)-oximeethers of 2,3-dihydro-1,8-naphthyridine and 2,3-dihydrothiopyrano[2,3-b]-pyridine: potential antihypertensive agents. Part IX 146
Development of fortified citrus olive oils: From their production to their nutraceutical properties on the cardiovascular system 146
The Renal Outer Medullary Potassium channel (ROMK): an intriguing pharmacological target for an innovative class of diuretic drugs 144
ANTI-ISCHEMIC ACTIVITY OF AN ANTIOXIDANT ALDOSE REDUCTASE INHIBITOR ON DIABETIC AND NON-DIABETIC RAT HEARTS 143
Morphiceptin analogues containing a dipeptide mimetic structure: An investigation on the bioactive topology at the mu-receptor 143
NO-glibenclamide derivatives: prototypes of a new class of nitric oxide-releasing anti-diabetic drugs 143
H2S donating corticosteroids: Design, synthesis and biological evaluation in a murine model of asthma 143
Enhancing the pharmacodynamic profile of a class of selective COX-2 inhibiting nitric oxide donors. 142
Totale 18.239
Salva come PNG Salva come JPEG
Categoria #
all - tutte 123.322
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 123.322
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.460 0 0 0 0 0 0 130 222 318 202 150 438
2021/20223.287 63 220 98 159 537 536 107 172 130 108 252 905
2022/20234.211 523 540 277 346 465 575 41 272 808 24 212 128
2023/20243.300 333 405 373 189 467 624 147 95 59 88 125 395
2024/202510.363 95 411 126 559 850 1.123 809 581 1.007 1.345 1.286 2.171
2025/20267.097 703 1.485 1.323 1.077 1.268 1.199 42 0 0 0 0 0
Totale 43.158